The effect of nutrients such as glucose and protein and various hormones on hepatic insulin and C-peptide metabolism will be studied in dogs. The experiments will be conducted in conscious dogs three weeks after placement of catheters in the femoral artery, portal and hepatic veins. Constant infusion of indocyanine green and tritiated glucose will enable me to calculate hepatic plasma flow and glucose turnover respectively. Fluxes of insulin, C-peptide and glucose across the liver will be measured using levels obtained in the three vessels and hepatic insulin extraction assessed. In certain experiments renal insulin and C-peptide metabolism will be assessed together with hepatic extraction and the relationship of urinary C-peptide to portal insulin secretion will be evaluated. Hepatocytes isolated from these livers after perfusion with collagenase containing solutions, will be used to define the number and affinity of the insulin receptors on these cells. Hepatic insulin and C-peptide extraction will be calculated after an overnight fast and at successive time intervals following administration of different stimuli. Changes in hepatic glucose balance and glucose turnover will be followed. The number and affinity of the insulin receptors on hepatocytes will be measured at critical time points when maximal change in insulin extraction occurs in order to determine whether changes in insulin extraction are mediated at the receptor level. The hepatic extraction of C-peptide under different conditions will thus be compared to that of insulin. The use of the peripheral C-peptide/Insulin molar ratio represents a non-invasive approach to quantitate the hepatic extraction of insulin and its accuracy will be directly measured. In addition, exogenous infusion of C-peptide will allow me to measure simultaneously the hepatic, renal, metabolic and urinary clearance of C-peptide and document any change in these parameters under different physiological conditions. It is therefore anticipated that these studies will further our understanding of in vivo insulin and C-peptide metabolism and define the relationship between the metabolism of insulin and its biological activity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK031842-04
Application #
3230378
Study Section
Metabolism Study Section (MET)
Project Start
1983-01-01
Project End
1986-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Sun, Juan; Mao, Li-Qun; Polonsky, Kenneth S et al. (2016) Pancreatic ?-Cell Death due to Pdx-1 Deficiency Requires Multi-BH Domain Protein Bax but Not Bak. J Biol Chem 291:13529-34
Ren, Decheng; Sun, Juan; Mao, Liqun et al. (2014) BH3-only molecule Bim mediates ?-cell death in IRS2 deficiency. Diabetes 63:3378-87
Ren, Decheng; Sun, Juan; Wang, Changzheng et al. (2014) Role of BH3-only molecules Bim and Puma in ?-cell death in Pdx1 deficiency. Diabetes 63:2744-50
Pedersen, Morten Gram; Mosekilde, Erik; Polonsky, Kenneth S et al. (2013) Complex patterns of metabolic and Ca²? entrainment in pancreatic islets by oscillatory glucose. Biophys J 105:29-39
Klein, Samuel; Fabbrini, Elisa; Patterson, Bruce W et al. (2012) Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity (Silver Spring) 20:1266-72
Reeds, Dominic N; Patterson, Bruce W; Okunade, Adewole et al. (2011) Ginseng and ginsenoside Re do not improve ?-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes. Diabetes Care 34:1071-6
Villareal, Dennis T; Robertson, Heather; Bell, Graeme I et al. (2010) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59:479-85
Wice, Burton M; Wang, Songyan; Crimmins, Dan L et al. (2010) Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem 285:19842-53
Cheverud, James M; Fawcett, Gloria L; Jarvis, Joseph P et al. (2010) Calpain-10 is a component of the obesity-related quantitative trait locus Adip1. J Lipid Res 51:907-13
Fujimoto, Kei; Chen, Yun; Polonsky, Kenneth S et al. (2010) Targeting cyclophilin D and the mitochondrial permeability transition enhances beta-cell survival and prevents diabetes in Pdx1 deficiency. Proc Natl Acad Sci U S A 107:10214-9

Showing the most recent 10 out of 120 publications